Cenra Inc. (TPE:3716)

Market Cap	5.01B -3.4%
Revenue (ttm)	8.54B -3.9%
Net Income	377.97M +14.7%
EPS	3.01 +11.8%
Shares Out	146.14M
PE Ratio	11.39
Forward PE	n/a
Dividend	1.00 (2.89%)
Ex-Dividend Date	n/a

Volume	410,856
Open	34.55
Previous Close	34.60
Day's Range	34.15 - 35.15
52-Week Range	31.55 - 38.70
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	May 27, 2026

About Cenra

Cenra Inc. engages in the research and development, manufacture, and sale of generic pharmaceutical and healthcare products for humans and animals. It offers active pharmaceutical ingredients, generic drugs for human use, over to the counter drugs, self-care products for the prevention of diseases, home care and cosmetics, and animal healthcare products. The company is also involved in the research and development, contracting manufacturing and international, and senior care services, as well as distributes and sells pharmaceutical brands. In a...

• Industry: Medical Distribution
• Sector: Healthcare
• Founded: 1952
• Employees: 542
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 3716

Financial Performance

In 2025, Cenra's revenue was 8.57 billion, a decrease of -3.91% compared to the previous year's 8.92 billion. Earnings were 300.07 million, a decrease of -5.44%.